临床试验：艾伯维的企业级人工智能文档创建平台 GAIA（由埃森哲赞助）.pdf

1、 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.Steven TroyDirector-Artificial Intelligence,R&D Global Therapeutics Platforms|AbbVieDarian Johnson

2、Managing Director,AWS Business Group|AccentureChris SinclairVice-President,R&D Global Therapeutics Platforms|AbbVieClinical Trials:AbbVies Enterprise AI-Powered Document Creation Platform GAIAA I M 1 1 8-S 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.AgendaIntroductionsWhy GAIA

3、Key Building Blocks of GAIAWhat Are we Doing to Unlock Additional GrowthWhat We Have Learned On Our JourneyAccelerating Clinical Horizon How GAIA Delivers First-Draft Automation 2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.Meet the AbbVie GAIA Innovation LeadersSteven Troy(He/H

4、im)Director-Artificial Intelligence,R&D Global Therapeutics Platforms|AbbVieStrategic AI leader driving innovation in regulated industries,specializing in Generative AI,ML,and NLP to transform Life Sciences.Chris Sinclair(He/Him)Vice-President,R&D Global Therapeutics Platforms|AbbVieTransformation l

5、eader driving innovation and cross-functional impact with deep experience spanning R&D,IT,Finance,and Patient Safety.Darian Johnson(He/Him)Managing Director,AWS Business Group|AccentureTechnology leader that works with clients like AbbVie to drive complex engagements at the intersection of data,AI,c

6、loud transformation and enterprise-scale innovation.2025,Amazon Web Services,Inc.or its affiliates.All rights reserved.At AbbVie,we recognized that the traditional approach to medical documentation had automation opportunities that could accelerate our time to patients.Our Generative AI Assistant(GA